Reliable Infrastructure for Tomorrow’s ATMP Production
The successful implementation of complex pharmaceutical and biotech projects begins long before a facility goes online. It is based on thorough planning, clearly defined processes, and the ability to integrate regulatory, technical, and construction requirements into a cohesive, functional overall concept. It was precisely this challenge that defined the PROVIREX Genome Editing Therapies GmbH project at its Hamburg site. There, a highly specialized cleanroom infrastructure was created for the manufacture of Advanced Therapy Medicinal Products (ATMPs) that meets the highest standards for quality, safety, and process stability.
PROVIREX develops innovative cell and gene therapies and, to do so, requires production environments that meet both GMP requirements and the specifications of biosafety level S3**. The new cleanrooms lay the foundation for the clinical application of novel therapeutic approaches and, at the same time, enable the production of CAR-T cell therapies under heightened safety requirements.
The project’s success was not due to a single technical solution, but rather to the collaboration of all parties involved. Only through early coordination of processes, building structure, cleanroom technology, and regulatory requirements were we able to achieve the ambitious project goals and bring the infrastructure online on schedule.
Controlled access to the cleanroom area via the hygiene airlock is an essential component of the GMP concept.
From Vision to State-of-the-Art Cleanroom Infrastructure
The particular challenge lay not only in the stringent regulatory requirements. The cleanrooms were built within an existing technology hub. The existing building had to be extensively adapted to meet the requirements of modern ATMP production. This brought numerous issues into focus that were critical to the project’s success: the integration of building services, the coordination of various trades, the implementation of regulatory requirements, and the development of safe material and personnel flows.
io provided comprehensive support for the project—from the initial concept through to qualified commissioning. Through close coordination among all participating disciplines, complex technical, regulatory, and structural requirements were successfully translated into a functional production environment.
Cleanroom Design at the Highest Safety Level
A key factor in the project’s success was the interdisciplinary planning approach. Experts in pharmaceutical and biotech engineering, architecture, building services engineering, and project management worked closely together to identify requirements early on and jointly develop solutions. This made it possible to identify potential conflicts as early as the planning phase and avoid time-consuming adjustments during implementation. The consistent focus on future production processes also ensured that the infrastructure was not only designed to comply with regulations but was also efficient and future-proof.
A particularly challenging aspect was combining traditional GMP cleanroom requirements with the specifications of biosafety level S3**. While GMP primarily ensures product quality, the requirements of the biosafety level also take into account the protection of employees and the environment. The planning therefore had to ensure that both sets of regulations could be implemented within an integrated concept. Differentiated pressure zone concepts, airlock systems, and clearly defined material and personnel flows now help ensure safe and stable operations.
The qualification of the cleanroom infrastructure took place in parallel with implementation and was an integral part of the project approach from the very beginning. The result is a modern production environment that meets the highest standards while also laying the groundwork for future innovations. The PROVIREX project exemplifies how challenging pharmaceutical and biotech infrastructures can be successfully realized through holistic planning, interdisciplinary collaboration, and consistent interface management.
